A high throughput screen identifies chemical modulators of the laminin-induced clustering of dystroglycan and aquaporin-4 in primary astrocytes

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Noël, Geoffroy ^a   Stevenson, Sarah ^a   Moukhles, Hakima ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AQUAPORIN 4; BETA DYSTROGLYCAN; CHLORANIL; FLUNARIZINE; GELATINASE A; LAMININ; REACTIVE OXYGEN METABOLITE; DYSTROGLYCAN; GELATIN; ORGANIC COMPOUND; PRINOMASTAT; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; MICROSCOPY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR LIBRARY; MOUSE; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; TIME;

MUS; RATTUS;

ANIMALS; AQUAPORIN 4; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CHLORANIL; DYSTROGLYCANS; FLUNARIZINE; GELATIN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LAMININ; MICE; MICROSCOPY; ORGANIC CHEMICALS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPRODUCIBILITY OF RESULTS; SMALL MOLECULE LIBRARIES; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 79952355111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017559     Document Type: Article

References (65)

1. Manley GT, Binder DK, Papadopoulos MC, Verkman AS, (2004) New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice. Neuroscience 129: 983-991.
2. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, et al. (1997) Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17: 171-180.
3. Auguste KI, Jin S, Uchida K, Yan D, Manley GT, et al. (2007) Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury. FASEB J 21: 108-116.
4. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, et al. (2000) Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6: 159-163.
5. Feng X, Papadopoulos MC, Liu J, Li L, Zhang D, et al. (2009) Sporadic obstructive hydrocephalus in Aqp4 null mice. J Neurosci Res 87: 1150-1155.
6. Ma T, Yang B, Gillespie A, Carlson EJ, Epstein CJ, et al. (1997) Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest 100: 957-962.
7. Yang B, Zador Z, Verkman AS, (2008) Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J Biol Chem 283: 15280-15286.
8. Bloch O, Auguste KI, Manley GT, Verkman AS, (2006) Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab 26: 1527-1537.
9. Bloch O, Papadopoulos MC, Manley GT, Verkman AS, (2005) Aquaporin-4 gene deletion in mice increases focal edema associated with staphylococcal brain abscess. J Neurochem 95: 254-262.
10. Tait MJ, Saadoun S, Bell BA, Verkman AS, Papadopoulos MC, (2010) Increased brain edema in aqp4-null mice in an experimental model of subarachnoid hemorrhage. Neuroscience 167: 60-67.
11. Detmers FJ, de Groot BL, Muller EM, Hinton A, Konings IB, et al. (2006) Quaternary ammonium compounds as water channel blockers. Specificity, potency, and site of action. J Biol Chem 281: 14207-14214.
12. Huber VJ, Tsujita M, Kwee IL, Nakada T, (2009) Inhibition of aquaporin 4 by antiepileptic drugs. Bioorg Med Chem 17: 418-424.
13. Huber VJ, (2009) Support for small molecule inhibition of aquaporin 4. Bioorg Med Chem 17: 425-426.
14. Huber VJ, Tsujita M, Yamazaki M, Sakimura K, Nakada T, (2007) Identification of arylsulfonamides as Aquaporin 4 inhibitors. Bioorg Med Chem Lett 17: 1270-1273.
15. Mola MG, Nicchia GP, Svelto M, Spray DC, Frigeri A, (2009) Automated cell-based assay for screening of aquaporin inhibitors. Anal Chem 81: 8219-8229.
16. Tanimura Y, Hiroaki Y, Fujiyoshi Y, (2009) Acetazolamide reversibly inhibits water conduction by aquaporin-4. J Struct Biol 166: 16-21.
17. Dibas A, Yang MH, He S, Bobich J, Yorio T, (2008) Changes in ocular aquaporin-4 (AQP4) expression following retinal injury. Mol Vis 14: 1770-1783.
18. Yang B, Zhang H, Verkman AS, (2008) Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides. Bioorg Med Chem 16: 7489-7493.
19. Mehler MF, (2000) Brain dystrophin, neurogenetics and mental retardation. Brain Res Brain Res Rev 32: 277-307.
20. Worton R, (1995) Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 270: 755-756.
21. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, et al. (1993) Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 268: 14972-14980.
22. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S, (1994) Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77: 675-686.
23. Peng HB, Ali AA, Daggett DF, Rauvala H, Hassell JR, et al. (1998) The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Commun 5: 475-489.
24. Sugita S, Saito F, Tang J, Satz J, Campbell K, et al. (2001) A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 154: 435-445.
25. Rurak J, Noel G, Lui L, Joshi B, Moukhles H, (2007) Distribution of potassium ion and water permeable channels at perivascular glia in brain and retina of the Large(myd) mouse. J Neurochem 103: 1940-1953.
26. Bragg AD, Amiry-Moghaddam M, Ottersen OP, Adams ME, Froehner SC, (2006) Assembly of a perivascular astrocyte protein scaffold at the mammalian blood-brain barrier is dependent on alpha-syntrophin. Glia 53: 879-890.
27. Guadagno E, Moukhles H, (2004) Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes. Glia 47: 138-149.
28. Noel G, Tham DK, Moukhles H, (2009) Interdependence of laminin-mediated clustering of lipid rafts and the dystrophin complex in astrocytes. J Biol Chem 284: 19694-19704.
29. Amiry-Moghaddam M, Otsuka T, Hurn PD, Traystman RJ, Haug FM, et al. (2003) An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc Natl Acad Sci U S A 100: 2106-2111.
30. Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, et al. (2001) Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc Natl Acad Sci U S A 98: 14108-14113.
31. Nico B, Frigeri A, Nicchia GP, Corsi P, Ribatti D, et al. (2003) Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia 42: 235-251.
32. Amiry-Moghaddam M, Frydenlund DS, Ottersen OP, (2004) Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 129: 999-1010.
33. Vajda Z, Pedersen M, Fuchtbauer EM, Wertz K, Stodkilde-Jorgensen H, et al. (2002) Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-null transgenic mice. Proc Natl Acad Sci U S A 99: 13131-13136.
34. Inglese J, Johnson RL, Simeonov A, Xia M, Zheng W, et al. (2007) High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 3: 466-479.
35. Yamada H, Saito F, Fukuta-Ohi H, Zhong D, Hase A, et al. (2001) Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 10: 1563-1569.
36. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, et al. (2006) Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 203: 1007-1019.
37. Li Z, Clarke MP, Barker MD, McKie N, (2005) TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights. Expert Rev Mol Med 7: 1-15.
38. Siraki AG, Chan TS, O'Brien PJ, (2004) Application of quantitative structure-toxicity relationships for the comparison of the cytotoxicity of 14 p-benzoquinone congeners in primary cultured rat hepatocytes versus PC12 cells. Toxicol Sci 81: 148-159.
39. Makinen PL, Makinen KK, (1988) Near stoichiometric, irreversible inactivation of bacterial collagenases by o-chloranil (3,4,5,6-tetrachloro-1,2-benzoquinone). Biochem Biophys Res Commun 153: 74-80.
40. Vajda Z, Promeneur D, Doczi T, Sulyok E, Frokiaer J, et al. (2000) Increased aquaporin-4 immunoreactivity in rat brain in response to systemic hyponatremia. Biochem Biophys Res Commun 270: 495-503.
41. Papadopoulos MC, Manley GT, Krishna S, Verkman AS, (2004) Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 18: 1291-1293.
42. Dahlhaus M, Almstadt E, Henschke P, Luttgert S, Appel KE, (1996) Oxidative DNA lesions in V79 cells mediated by pentachlorophenol metabolites. Arch Toxicol 70: 457-460.
43. Kim SR, Lee JY, Lee MY, Chung SM, Bae ON, et al. (2001) Association of quinone-induced platelet anti-aggregation with cytotoxicity. Toxicol Sci 62: 176-182.
44. Fischer R, Schliess F, Haussinger D, (1997) Characterization of the hypo-osmolarity-induced Ca2+ response in cultured rat astrocytes. Glia 20: 51-58.
45. Kim-Lee MH, Stokes BT, Yates AJ, (1992) Reperfusion paradox: a novel mode of glial cell injury. Glia 5: 56-64.
46. Zumkeller M, Dietz H, (1996) Ultrastructural changes in the blood-brain barrier in rats after treatment with nimodipine and flunarizine. A comparison. Neurosurg Rev 19: 253-260.
47. Abiko H, Mizoi K, Suzuki J, Oba M, Yoshimoto T, (1988) Cerebral protective effect of flunarizine in a canine model of cerebral ischaemia. Neurol Res 10: 145-150.
48. Leybaert L, De Ley G, (1994) Interstitial and tissue cations and electrical potential after experimental spinal cord injury. Exp Brain Res 100: 369-375.
49. Hartmann A, (1986) Is there a need for alternative approaches in the therapy of cerebrovascular disorders? Eur Neurol 25 (Suppl 1): 7-26.
50. Michaluk P, Kolodziej L, Mioduszewska B, Wilczynski GM, Dzwonek J, et al. (2007) Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. J Biol Chem 282: 16036-16041.
51. Singh J, Itahana Y, Knight-Krajewski S, Kanagawa M, Campbell KP, et al. (2004) Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res 64: 6152-6159.
52. Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, et al. (2007) Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem 101: 566-576.
53. Pun PB, Lu J, Moochhala S, (2009) Involvement of ROS in BBB dysfunction. Free Radic Res 43: 348-364.
54. Meli DN, Christen S, Leib SL, (2003) Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J Infect Dis 187: 1411-1415.
55. Milner R, Hung S, Wang X, Spatz M, del Zoppo GJ, (2008) The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent. J Cereb Blood Flow Metab 28: 812-823.
56. Leonardo CC, Hall AA, Collier LA, Gottschall PE, Pennypacker KR, (2009) Inhibition of gelatinase activity reduces neural injury in an ex vivo model of hypoxia-ischemia. Neuroscience 160: 755-766.
57. Paggi P, De Stefano ME, Petrucci TC, (2006) Synaptic remodeling induced by axotomy of superior cervical ganglion neurons: Involvement of metalloproteinase-2. J Physiol Paris 99: 119-124.
58. Leone L, De Stefano ME, Del Signore A, Petrucci TC, Paggi P, (2005) Axotomy of sympathetic neurons activates the metalloproteinase-2 enzymatic pathway. J Neuropathol Exp Neurol 64: 1007-1017.
59. Zhong D, Saito F, Saito Y, Nakamura A, Shimizu T, et al. (2006) Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan. Biochem Biophys Res Commun 345: 867-871.
60. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, et al. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39-44.
61. Fisher JF, Mobashery S, (2006) Recent advances in MMP inhibitor design. Cancer Metastasis Rev 25: 115-136.
62. Egeblad M, Werb Z, (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
63. Lafleur MA, Handsley MM, Edwards DR, (2003) Metalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med 5: 1-39.
64. Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, et al. (2004) Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. J Biol Chem 279: 8592-8601.
65. Gursoy-Ozdemir Y, Can A, Dalkara T, (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35: 1449-1453.